NCT04290832 is a NA clinical trial of CO Intervention in Abortion, Induced, sponsored by Ipas.

Who is sponsoring NCT04290832?

NCT04290832 is sponsored by Ipas.

What drugs are being tested in NCT04290832?

Interventions in NCT04290832: CO Intervention.

What condition does NCT04290832 study?

NCT04290832 studies Abortion, Induced, Abortion, Incomplete.

Is NCT04290832 still recruiting?

NCT04290832 is currently terminated. Last updated 29 July 2020.

Last reviewed 2020-07-29 · How we verify

NCT04290832

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa

Terminated NA Last updated 29 July 2020

What this trial tests

NA trial testing CO Intervention in Abortion, Induced in 317 participants. Terminated before completion.

Timeline

13 February 2020

Primary endpoint
17 March 2020

30 June 2020

Quick facts

Lead sponsor	Ipas
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	317
Start date	13 February 2020
Primary completion	17 March 2020
Estimated completion	30 June 2020
Sites	2 locations across South Africa, Mexico

Drugs / interventions tested

CO Intervention

Conditions studied

Abortion, Induced — all drugs for Abortion, Induced →
Abortion, Incomplete — all drugs for Abortion, Incomplete →

Sponsor

Ipas — full company profile →

Who can join

Eligibility, any sex, with Abortion, Induced or Abortion, Incomplete. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this research is to develop strategies and interventions to mitigate the impact of conscientious objection on women's access to safe abortion care in Mexico and South Africa using a user-centered design approach and test the feasibility and effectiveness of these interventions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Stigma towards women requesting abortion and association with health facility staff facilitation and obstruction of abortion care in South Africa.
Jim A, Magwentshu M, Menzel J, Küng SA, et al · · 2023 · cited 7× · PMID 37396569 · DOI 10.3389/fgwh.2023.1142638

Verify or expand the search:

Other Ipas trials

Trials by the same sponsor.

NCT04181541 — Midlevel Versus Physician-provided Medical Abortion in the Second Trimester · NA · completed
NCT04242212 — Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion · unknown
NCT03539315 — Adaptation and Testing of the Addressing Reproductive Coercion in HEalth Settings (ARCHES) Intervention in Bangladesh · NA · completed
NCT03727308 — Study of Clinic-based Versus Self-use of Medical Abortion Pills · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04290832 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ipas
Last refreshed: 29 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04290832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing